T50.A13S Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, sequela

Name of the Condition

• Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, sequela

Summary

This condition describes poisoning resulting from exposure to a pertussis (whooping cough) vaccine, either alone or in combination with other vaccine components, due to assault, with subsequent residual effects. The clinical presentation and management depend on the nature of the exposure, the individual's response, and the persistence of symptoms or complications.

Causes

Assault-related poisoning may occur due to deliberate administration of the vaccine by another person, often as part of a violent or harmful act. The pertussis vaccine component, such as the inactivated or acellular antigen, is the primary agent involved in the toxic or adverse reaction. Sequela refers to residual effects following the initial poisoning event.

Risk Factors

• Victim of physical or psychological assault
• Exposure to vaccine through forced administration
• Lack of consent during vaccine administration
• Situations involving coercion or violence
• Prior adverse reactions to pertussis vaccine components

Symptoms

• Localized reactions at the injection site (e.g., swelling, redness)
• Systemic symptoms such as fever, irritability, or malaise
• Rare severe reactions like allergic responses or respiratory distress
• Psychological symptoms: distress, confusion, or altered mental status
• Persistent or delayed effects (sequela) following the initial event

Diagnosis

Diagnosis is based on a history of assault-related vaccine exposure, clinical evaluation of symptoms, and exclusion of other causes. Laboratory tests may assess for vaccine-related antibodies or adverse reactions. Imaging or other diagnostic tools may be used to evaluate residual effects (sequela).

Treatment Options

Treatment focuses on managing acute symptoms and addressing residual effects. This may include supportive care, antihistamines for allergic reactions, or psychological support for trauma-related symptoms. Long-term management depends on the nature of the sequela.

Prognosis and Follow-Up

Prognosis varies based on the severity of the initial poisoning and the presence of sequela. Follow-up care may involve monitoring for persistent symptoms, rehabilitation for physical or psychological effects, and regular assessments to address ongoing complications.

Complications

• Persistent local or systemic reactions
• Psychological trauma or PTSD
• Long-term allergic sensitization
• Respiratory or neurological sequelae
• Delayed adverse effects from vaccine components

Lifestyle & Prevention

• Avoidance of known triggers or vaccine components
• Psychological counseling for trauma-related symptoms
• Adherence to follow-up care plans
• Education on recognizing and reporting adverse reactions

When to Seek Professional Help

Seek immediate medical attention for severe symptoms (e.g., difficulty breathing, high fever, or altered mental status). Consult a healthcare provider for persistent or worsening symptoms, especially if sequela are suspected.

Tips for Medical Coders

Document the assault-related nature of the poisoning and any residual effects (sequela) clearly. Ensure the code T50.A13S is used when the condition represents poisoning by pertussis vaccine due to assault with subsequent sequela. Include details about the vaccine type, administration context, and any persistent symptoms to support accurate coding.